San Francisco start - up Brain Genomics , a Y Combinator graduate , has raised $ 32 m in a series A round led by DFJ . It is developing drugs to treat amyotrophic lateral syndrome ( ALS ) , also known as Lou Gehrig 's disease , by comparing samples of cells from people who have died from the disease with those of healthy brains and also uses mice to study human diseases . With the new cash, Verge wants to start programs in Parkinson’s disease and two others Its teams then use machine - learning algorithms to identify the genes triggering ALS . The company is focusing on finding chemical molecules that can be turned into drugs , and aims to expand its research to include Parkinson ’s disease .
San Francisco start - up Brain Genomics , a Y Combinator graduate , has raised $ 32 m in a series A round led by DFJ . It is developing drugs to treat amyotrophic lateral syndrome ( ALS ) , also known as Lou Gehrig 's disease , by comparing samples of cells from people who have died from the disease with those of healthy brains and also uses mice to study human diseases . Its teams then use machine - learning algorithms to identify the genes triggering ALS . The company is focusing on finding chemical molecules that can be turned into drugs , and aims to expand its research to include Parkinson ’s disease .